ProCE Banner Activity

Post Immune Checkpoint Inhibitor Therapy for RCC: Second-line Therapy and Beyond

Slideset

Download these slides from a live symposium to learn more about second-line therapy and beyond for RCC.

Released: June 04, 2023

Expiration: June 03, 2024

Share

Faculty

Katy Beckermann

Katy Beckermann, MD, PhD

Assistant Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AVEO Pharmaceuticals, Inc. (“AVEO Oncology”) and Eisai. Supported by a medical education grant from Exelixis, Inc.

AVEO Pharmaceuticals, Inc.

Eisai

Exelixis, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner